倾向性得分匹配作为生物标志物队列设计和omics数据分析的有效策略
Masaki Maekawa1,2,3, Atsushi Tanaka1,2,3, Makiko Ogawa1,2,3
1Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, United States of America.
PloS one
|May 2, 2024
概括
倾向性得分匹配 (PSM) 简化了对生物标志物发现的OMIC数据分析. 这种方法在较小的患者队伍中有效地识别出预后生物标志物,降低了癌症研究的成本和复杂性.
科学领域:
- 生物统计学 生物统计学
- 基因组学就是基因组学.
- 蛋白质组学是指蛋白质组学.
背景情况:
- 由于其多维性质,Omics数据分析在识别显著生物标记因子方面存在挑战.
- 生物和临床数据的复杂性阻碍了特定生物标志物显著性的推断.
研究的目的:
- 探索倾向分数匹配 (PSM) 的实用性,以简化OMIC数据分析.
- 评估PSM在确定结直肠癌 (CRC) 队列中的预后生物标志物的有效性.
主要方法:
- 应用了倾向得分匹配 (PSM),这是一个减少混因素的统计技术.
- 分析了两组CRC患者数据集:一个具有免疫组织化学蛋白标记物 (544个组织),另一个具有RNA-seq概况 (163例).
- 通过比较PSM前后的分析结果来评估效率.
主要成果:
- PSM使患者特征之间的直接比较成为可能,揭示了新的预后生物标志物.
- 最佳匹配的组将混效应降到最低,允许强大的生物标志物提取.
- 与传统分析相比,PSM需要较少的癌症病例和较小的患者队伍.
结论:
- 倾向性得分匹配 (PSM) 为多原子数据分析提供了一种高效和成本效益的策略.
- 在临床试验设计中,PSM可以增强生物标志物的发现.
- 这种方法有助于识别显著的生物标志物,样本大小减少.
更多相关视频
相关概念视频
Sign Test for Matched Pairs
131
The sign test for matched pairs offers a robust method for comparing two paired samples, often for the effects of an intervention in one of them. This method is very useful in situations where the underlying distribution of the data is unknown. The test compares two related samples—often pre- and post-treatment measurements on the same subjects—to determine if there are significant differences in their median values.
To conduct the sign test, we first calculate the differences in...
To conduct the sign test, we first calculate the differences in...
131
Comparing the Survival Analysis of Two or More Groups
178
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
178
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133


